{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:45:58Z","timestamp":1769107558718,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Revisions are mainly caused by wear debris-induced aseptic loosening. How to effectively suppress debris-induced periprosthetic osteolysis has become an urgent problem. Both zoledronic acid and teriparatide can increase the bone mass around prostheses and increase the stability of prostheses. A hypothesis was proposed: the combination of the two drugs may have a better treatment effect than the use of either drug alone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We created a rabbit model to study the effect and mechanism of the combination of zoledronic acid and teriparatide in the treatment of aseptic loosening. Thirty-two adult male New Zealand white rabbits were selected and treated with TKA surgery, and a titanium rod prosthesis coated evenly with micrometre-sized titanium debris was implanted into the right femoral medullary cavity. All rabbits were randomized into four groups (control group\u2009=\u20098, zoledronic acid group\u2009=\u20098, teriparatide group\u2009=\u20098, and zoledronic acid + teriparatide group\u2009=\u20098). All the animals were sacrificed in the 12th week, and X-ray analyses, H&amp;E staining, Goldner-Masson trichrome staining, von Kossa staining, and RT-PCR and Western blotting of the mRNA and protein of OCN, OPG, RANKL and TRAP5b in the interface membrane tissues around the prostheses were immediately carried out.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results shown that both zoledronic acid and teriparatide could inhibit debris-induced peri-prosthetic osteolysis and promote new bone formation. Zoledronic acid was more capable of inhibiting osteoclast activation and peri-prosthetic osteolysis, while teriparatide was more capable of promoting osteoblast function and peri-prosthetic bone integration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This research confirmed that the combination of zoledronic acid and teriparatide could prevent and treat aseptic loosening of the prosthesis more effectively. However, the safety of this combination and the feasibility of long-term application have not been ensured, and the clinical application requires further experiments and clinical research support.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-021-04458-4","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T09:03:43Z","timestamp":1624525423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Zoledronic acid and teriparatide have a complementary therapeutic effect on aseptic loosening in a rabbit model"],"prefix":"10.1186","volume":"22","author":[{"given":"Peng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-qian","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"issue":"2","key":"4458_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/17453670610045902","volume":"77","author":"M Sundfeldt","year":"2006","unstructured":"Sundfeldt M, Carlsson LV, Johansson CB, Thomsen P, Gretzer C. Aseptic loosening, not only a question of wear: a review of different theories. Acta Orthop. 2006;77(2):177\u201397. https:\/\/doi.org\/10.1080\/17453670610045902 Epub 2006\/06\/06. doi: PubMed PMID: 16752278.","journal-title":"Acta Orthop"},{"key":"4458_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.5435\/00124635-200800001-00003","volume":"16","author":"A Marshall","year":"2008","unstructured":"Marshall A, Ries MD, Paprosky W, Clinic IWS. How prevalent are implant wear and osteolysis, and how has the scope of osteolysis changed since 2000? J Am Acad Orthop Sur. 2008;16:S1\u20136. https:\/\/doi.org\/10.5435\/00124635-200800001-00003 PubMed PMID: WOS:000257474600003.","journal-title":"J Am Acad Orthop Sur"},{"issue":"7","key":"4458_CR3","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1007\/s11999-009-1066-5","volume":"468","author":"PN Baker","year":"2010","unstructured":"Baker PN, McMurtry IA, Chuter G, Port A, Anderson J. THA with the ABG I prosthesis at 15 Years: excellent survival with minimal osteolysis. Clin Orthop Relat R. 2010;468(7):1855\u201361. https:\/\/doi.org\/10.1007\/s11999-009-1066-5 PubMed PMID: WOS:000278521400021.","journal-title":"Clin Orthop Relat R"},{"key":"4458_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/01.blo.0000142288.66246.4d","volume":"427","author":"KJ Saleh","year":"2004","unstructured":"Saleh KJ, Thongtrangan I, Schwarz EM. Osteolysis - medical and surgical approaches. Clin Orthop Relat R. 2004;427:138\u201347. https:\/\/doi.org\/10.1097\/01.blo.0000142288.66246.4d PubMed PMID: WOS:000224422500024.","journal-title":"Clin Orthop Relat R"},{"issue":"12","key":"4458_CR5","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.2106\/Jbjs.G.00043","volume":"89a","author":"A Cale","year":"2007","unstructured":"Cale A, Christensen CP, Greenwald AS, McKellop H. Clinical performance of highly cross-linked polyethylenes in total hip arthroplasty. J Bone Joint Surg Am. 2007;89a(12):2779\u201386. https:\/\/doi.org\/10.2106\/Jbjs.G.00043 PubMed PMID: WOS:000251401900026.","journal-title":"J Bone Joint Surg Am"},{"issue":"3","key":"4458_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jinf.2014.05.003","volume":"69","author":"A Ribera","year":"2014","unstructured":"Ribera A, Morata L, Moranas J, Agullo JL, Martinez JC, Lopez Y, et al. Clinical and microbiological findings in prosthetic joint replacement due to aseptic loosening. J Infection. 2014;69(3):235\u201343. https:\/\/doi.org\/10.1016\/j.jinf.2014.05.003 PubMed PMID: WOS:000341988500004.","journal-title":"J Infection"},{"issue":"4","key":"4458_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1055\/s-0030-1250108","volume":"148","author":"D Cadosch","year":"2010","unstructured":"Cadosch D, Schlett CL, Gautschi OP, Frei HC, Filgueira L. Metal Ions: Important Co-Players in Aseptic Loosening. Z Orthop Unfallchir. 2010;148(4):393\u20137. https:\/\/doi.org\/10.1055\/s-0030-1250108 PubMed PMID: WOS:000281465300003.","journal-title":"Z Orthop Unfallchir"},{"issue":"6","key":"4458_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00292-006-0868-4","volume":"27","author":"M Otto","year":"2006","unstructured":"Otto M, Kriegsmann J, Gehrke T, Bertz S. Wear particles: key to aseptic prosthetic loosening? Pathologe. 2006;27(6):447\u201360. https:\/\/doi.org\/10.1007\/s00292-006-0868-4 PubMed PMID: WOS:000242672500008.","journal-title":"Pathologe"},{"issue":"6","key":"4458_CR9","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2106\/00004623-199306000-00002","volume":"75a","author":"SM Horowitz","year":"1993","unstructured":"Horowitz SM, Doty SB, Lane JM, Burstein AH. Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone-resorption. J Bone Joint Surg Am. 1993;75a(6):802\u201313. https:\/\/doi.org\/10.2106\/00004623-199306000-00002 PubMed PMID: WOS:A1993LK82800002.","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"4458_CR10","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/art.27400","volume":"62","author":"S Shimizu","year":"2010","unstructured":"Shimizu S, Okuda N, Kato N, Rittling SR, Okawa A, Shinomiya K, et al. Osteopontin deficiency impairs wear debris-induced osteolysis via regulation of cytokine secretion from murine macrophages. Arthritis Rheum. 2010;62(5):1329\u201337. https:\/\/doi.org\/10.1002\/art.27400 Epub 2010\/02\/16. PubMed PMID: 20155835.","journal-title":"Arthritis Rheum"},{"key":"4458_CR11","first-page":"201","volume":"62","author":"SB Goodman","year":"2013","unstructured":"Goodman SB, Gibon E, Yao Z. The basic science of periprosthetic osteolysis. Instr Course Lect. 2013;62:201\u20136 Epub 2013\/02\/12. PubMed PMID: 23395025; PubMed Central PMCID: PMCPMC3766766.","journal-title":"Instr Course Lect"},{"issue":"3","key":"4458_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00223-008-9104-y","volume":"82","author":"AI Idris","year":"2008","unstructured":"Idris AI, Rojas J, Greig IR, Van't Hof RJ, Ralston SH. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif Tissue Int. 2008;82(3):191\u2013201. https:\/\/doi.org\/10.1007\/s00223-008-9104-y Epub 2008\/02\/09. PubMed PMID: 18259679.","journal-title":"Calcif Tissue Int"},{"issue":"18","key":"4458_CR13","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1016\/j.biomaterials.2003.11.024","volume":"25","author":"GI Im","year":"2004","unstructured":"Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials. 2004;25(18):4105\u201315. https:\/\/doi.org\/10.1016\/j.biomaterials.2003.11.024 Epub 2004\/03\/30. PubMed PMID: 15046901.","journal-title":"Biomaterials."},{"issue":"1","key":"4458_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bone.2003.08.013","volume":"34","author":"B Pan","year":"2004","unstructured":"Pan B, To LB, Farrugia AN, Findlay DM, Green J, Gronthos S, et al. The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone. 2004;34(1):112\u201323. https:\/\/doi.org\/10.1016\/j.bone.2003.08.013 Epub 2004\/01\/31. PubMed PMID: 14751568.","journal-title":"Bone."},{"issue":"2","key":"4458_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2106\/00004623-200202000-00011","volume":"84","author":"PJ Millett","year":"2002","unstructured":"Millett PJ, Allen MJ, Bostrom MP. Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Joint Surg Am. 2002;84(2):236\u201349. https:\/\/doi.org\/10.2106\/00004623-200202000-00011 Epub 2002\/02\/28. PubMed PMID: 11861730.","journal-title":"J Bone Joint Surg Am"},{"issue":"6","key":"4458_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00223-005-0062-3","volume":"77","author":"LM Wise","year":"2005","unstructured":"Wise LM, Waldman SD, Kasra M, Cheung R, Binnington A, Kandel RA, et al. Effect of zoledronate on bone quality in the treatment of aseptic loosening of hip arthroplasty in the dog. Calcif Tissue Int. 2005;77(6):367\u201375. Epub 2005\/12\/20. PubMed PMID: 16362454. https:\/\/doi.org\/10.1007\/s00223-005-0062-3.","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"4458_CR17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/jor.1100180602","volume":"18","author":"EM Schwarz","year":"2000","unstructured":"Schwarz EM, Benz EB, Lu AP, Goater JJ, Mollano AV, Rosier RN, et al. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res. 2000;18(6):849\u201355. Epub 2001\/02\/24. PubMed PMID: 11192243. https:\/\/doi.org\/10.1002\/jor.1100180602.","journal-title":"J Orthop Res"},{"issue":"6","key":"4458_CR18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1507\/endocrj.52.667","volume":"52","author":"SW Kim","year":"2005","unstructured":"Kim SW, Park DJ, Park KS, Kim SY, Cho BY, Lee HK, et al. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis. Endocr J. 2005;52(6):667\u201374. https:\/\/doi.org\/10.1507\/endocrj.52.667 PubMed PMID: WOS:000234793800003.","journal-title":"Endocr J"},{"key":"4458_CR19","doi-asserted-by":"publisher","first-page":"ARTN 16","DOI":"10.1186\/s41232-018-0074-9","volume":"38","author":"J Kaneko","year":"2018","unstructured":"Kaneko J, Okinaga T, Hikiji H, Ariyoshi W, Yoshiga D, Habu M, et al. Zoledronic acid exacerbates inflammation through M1 macrophage polarization. Inflamm Regen. 2018;38:ARTN 16. https:\/\/doi.org\/10.1186\/s41232-018-0074-9 PubMed PMID: WOS:000448308700001.","journal-title":"Inflamm Regen"},{"issue":"17","key":"4458_CR20","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s40265-016-0662-4","volume":"76","author":"S Dhillon","year":"2016","unstructured":"Dhillon S. Zoledronic acid (Reclast((R)), Aclasta((R))): a review in osteoporosis. Drugs. 2016;76(17):1683\u201397. https:\/\/doi.org\/10.1007\/s40265-016-0662-4 Epub 2016\/11\/20. PubMed PMID: 27864686.","journal-title":"Drugs."},{"issue":"2","key":"4458_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1530\/Joe-14-0424","volume":"223","author":"T Standal","year":"2014","unstructured":"Standal T, Johnson RW, McGregor NE, Poulton IJ, Ho PWM, Martin TJ, et al. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation. J Endocrinol. 2014;223(2):181\u201390. https:\/\/doi.org\/10.1530\/Joe-14-0424 PubMed PMID: WOS:000343659000011.","journal-title":"J Endocrinol"},{"issue":"3","key":"4458_CR22","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1210\/en.2013-1915","volume":"154","author":"R Kuriwaka-Kido","year":"2013","unstructured":"Kuriwaka-Kido R, Kido S, Miyatani Y, Ito Y, Kondo T, Omatsu T, et al. Parathyroid Hormone (1\u201334) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess. Endocrinology. 2013;154(3):1156\u201367. https:\/\/doi.org\/10.1210\/en.2013-1915 PubMed PMID: WOS:000315293100017.","journal-title":"Endocrinology"},{"key":"4458_CR23","doi-asserted-by":"publisher","unstructured":"Skripitz R, Aspenberg P. Early effect of parathyroid hormone (1\u201334) on implant fixation. Clin Orthop Relat R. 2001;(392):427\u201332. https:\/\/doi.org\/10.1097\/00003086-200111000-00056.PubMed PMID: WOS:000172087100056.","DOI":"10.1097\/00003086-200111000-00056.PubMed"},{"issue":"5","key":"4458_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00774-017-0865-0","volume":"36","author":"T Dohke","year":"2018","unstructured":"Dohke T, Iba K, Hanaka M, Kanaya K, Okazaki S, Yamashita T. Teriparatide rapidly improves pain-like behavior in ovariectomized mice in association with the downregulation of inflammatory cytokine expression. J Bone Miner Metab. 2018;36(5):499\u2013507. https:\/\/doi.org\/10.1007\/s00774-017-0865-0 PubMed PMID: WOS:000442855100001.","journal-title":"J Bone Miner Metab"},{"issue":"10","key":"4458_CR25","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1002\/art.22134","volume":"54","author":"T Koreny","year":"2006","unstructured":"Koreny T, Tunyogi-Csapo M, Gal I, Vermes C, Jacobs JJ, Glant TT. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum. 2006;54(10):3221\u201332. https:\/\/doi.org\/10.1002\/art.22134 PubMed PMID: WOS:000241260800022.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"4458_CR26","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1525-1594.2009.00736.x","volume":"33","author":"A Beraudi","year":"2009","unstructured":"Beraudi A, Stea S, Cremonini S, Visentin M, Toni A. Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty. Artif Organs. 2009;33(7):538\u201343. https:\/\/doi.org\/10.1111\/j.1525-1594.2009.00736.x PubMed PMID: WOS:000267170200006.","journal-title":"Artif Organs"},{"issue":"5","key":"4458_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/jor.20342","volume":"25","author":"SY Yang","year":"2007","unstructured":"Yang SY, Yu HY, Gong WM, Wu B, Mayton L, Costello R, et al. Murine model of prosthesis failure for the long-term study of aseptic loosening. J Orthop Res. 2007;25(5):603\u201311. https:\/\/doi.org\/10.1002\/jor.20342 PubMed PMID: WOS:000245728000005.","journal-title":"J Orthop Res"},{"issue":"4","key":"4458_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.arth.2007.06.010","volume":"23","author":"Y Qian","year":"2008","unstructured":"Qian Y, Zeng BF, Zhang XL, Jiang Y. Substance P stimulates production of interleukin 1beta and tumor necrosis factor alpha in fibroblasts from hip periprosthetic membrane. J Arthroplast. 2008;23(4):581\u20135. https:\/\/doi.org\/10.1016\/j.arth.2007.06.010 Epub 2008\/06\/03. PubMed PMID: 18514878.","journal-title":"J Arthroplast"},{"issue":"6","key":"4458_CR29","first-page":"545","volume":"31","author":"RZ Tashjian","year":"2008","unstructured":"Tashjian RZ, Lin C, Aswad B, Terek RM. 11beta-hydroxysteroid dehydrogenase type 1 expression in periprosthetic osteolysis. Orthopedics. 2008;31(6):545 Epub 2009\/03\/19. PubMed PMID: 19292355.","journal-title":"Orthopedics."},{"issue":"11","key":"4458_CR30","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/jbm.a.35803","volume":"104","author":"K Brulefert","year":"2016","unstructured":"Brulefert K, Cordova LA, Brulin B, Faucon A, Hulin P, Nedellec S, et al. Pro-osteoclastic in vitro effect of polyethylene-like nanoparticles: involvement in the pathogenesis of implant aseptic loosening. J Biomed Mater Res A. 2016;104(11):2649\u201357. https:\/\/doi.org\/10.1002\/jbm.a.35803 Epub 2016\/06\/03. PubMed PMID: 27254768.","journal-title":"J Biomed Mater Res A"},{"key":"4458_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.blo.0000246531.59876.a8","volume":"453","author":"CT Talmo","year":"2006","unstructured":"Talmo CT, Shanbhag AS, Rubash HE. Nonsurgical management of osteolysis: challenges and opportunities. Clin Orthop Relat Res. 2006;453:254\u201364. https:\/\/doi.org\/10.1097\/01.blo.0000246531.59876.a8 Epub 2006\/10\/04. PubMed PMID: 17016218.","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"4458_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jbm.a.32836","volume":"95a","author":"DC Geng","year":"2010","unstructured":"Geng DC, Xu YZ, Yang HL, Zhu XS, Zhu GM, Wang XB. Inhibition of titanium particle-induced inflammatory osteolysis through inactivation of cannabinoid receptor 2 by AM630. J Biomed Mater Res Part A. 2010;95a(1):321\u20136. https:\/\/doi.org\/10.1002\/jbm.a.32836 PubMed PMID: WOS:000281448700033.","journal-title":"J Biomed Mater Res Part A"},{"issue":"1","key":"4458_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","volume":"15","author":"LC Hofbauer","year":"2000","unstructured":"Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res. 2000;15(1):2\u201312. https:\/\/doi.org\/10.1359\/jbmr.2000.15.1.2 PubMed PMID: WOS:000084420800003.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"4458_CR34","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3892\/ijmm.2011.778","volume":"28","author":"K Lochner","year":"2011","unstructured":"Lochner K, Fritsche A, Jonitz A, Hansmann D, Mueller P, Mueller-Hilke B, et al. The potential role of human osteoblasts for periprosthetic osteolysis following exposure to wear particles. Int J Mol Med. 2011;28(6):1055\u201363. https:\/\/doi.org\/10.3892\/ijmm.2011.778 PubMed PMID: WOS:000296314600020.","journal-title":"Int J Mol Med"},{"issue":"6","key":"4458_CR35","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0736-0266(03)00081-0","volume":"21","author":"S Abbas","year":"2003","unstructured":"Abbas S, Clohisy JC, Abu-Amer Y. Mitogen-activated protein (MAP) kinases mediate PMMA-induction of osteoclasts. J Orthop Res. 2003;21(6):1041\u20138. https:\/\/doi.org\/10.1016\/S0736-0266(03)00081-0 PubMed PMID: WOS:000186144200012.","journal-title":"J Orthop Res"},{"issue":"1","key":"4458_CR36","first-page":"1","volume":"79","author":"YP Jiang","year":"2013","unstructured":"Jiang YP, Jia TH, Wooley PH, Yang SY. Current research in the pathogenesis of aseptic implant loosening associated with particulate wear debris. Acta Orthop Belg. 2013;79(1):1\u20139 PubMed PMID: WOS:000326420500001.","journal-title":"Acta Orthop Belg"},{"issue":"12","key":"4458_CR37","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1080\/15548627.2015.1106779","volume":"11","author":"ZH Wang","year":"2015","unstructured":"Wang ZH, Liu NC, Liu K, Zhou G, Gan JJ, Wang ZZ, et al. Autophagy mediated CoCrMo particle-induced peri-implant osteolysis by promoting osteoblast apoptosis. Autophagy. 2015;11(12):2358\u201369. https:\/\/doi.org\/10.1080\/15548627.2015.1106779 PubMed PMID: WOS:000367806300019.","journal-title":"Autophagy"},{"issue":"3","key":"4458_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/rb\/rbv002","volume":"2","author":"YY Zhang","year":"2015","unstructured":"Zhang YY, Lin Y, Xiao LL, Feng EY, Wang WL, Lin LQ. The effects of icariine concentration on osteoclasts bone resorption induced by titanium particles in vitro. Regen Biomater. 2015;2(3):197\u2013202. https:\/\/doi.org\/10.1093\/rb\/rbv002 PubMed PMID: WOS:000218550700005.","journal-title":"Regen Biomater"},{"issue":"2","key":"4458_CR39","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/jbm.b.30101","volume":"71b","author":"M Zenios","year":"2004","unstructured":"Zenios M, Nokes L, Galasko CSB. Effect of a bisphosphonate, disodiurn pamidronate, on the quasi-static flexural properties of palacos R acrylic bone cement. J Biomed Mater Res B. 2004;71b(2):322\u20136. https:\/\/doi.org\/10.1002\/jbm.b.30101 PubMed PMID: WOS:000224846700013.","journal-title":"J Biomed Mater Res B"},{"issue":"Suppl 7","key":"4458_CR40","first-page":"S53","volume":"5","author":"AE Goodship","year":"1994","unstructured":"Goodship AE, Walker PC, McNally D, Chambers T, Green JR. Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone. Ann Oncol. 1994;5(Suppl 7):S53\u20135 Epub 1994\/01\/01. PubMed PMID: 7873463.","journal-title":"Ann Oncol"},{"key":"4458_CR41","doi-asserted-by":"publisher","unstructured":"Koivukangas A, Taukkanen J, Kippo K, Jamsa T, Hannuniemi R, Pasanen I, et al. Long-term administration of clodronate does not prevent fracture healing in rats. Clin Orthop Relat R. 2003;(408):268\u201378. https:\/\/doi.org\/10.1097\/01.blo.0000053054.62337.e1 PubMed PMID: WOS:000181436700037.","DOI":"10.1097\/01.blo.0000053054.62337.e1"},{"issue":"3","key":"4458_CR42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/jbmr.2001.16.3.429","volume":"16","author":"CY Li","year":"2001","unstructured":"Li CY, Mori S, Li JL, Kaji Y, Akiyama T, Kawanishi J, et al. Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J Bone Miner Res. 2001;16(3):429\u201336. https:\/\/doi.org\/10.1359\/jbmr.2001.16.3.429 PubMed PMID: WOS:000167157700001.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"4458_CR43","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1302\/0301-620x.93b6.24257","volume":"93b","author":"N Yalcin","year":"2011","unstructured":"Yalcin N, Ozturk A, Ozkan Y, Celimli N, Ozocak E, Erdogan A, et al. The effects of zoledronic acid and hyperbaric oxygen on posterior lumbar fusion in a rabbit model. J Bone Joint Surg Br. 2011;93b(6):793\u2013800. https:\/\/doi.org\/10.1302\/0301-620x.93b6.24257 PubMed PMID: WOS:000290714900015.","journal-title":"J Bone Joint Surg Br"},{"issue":"10","key":"4458_CR44","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.2106\/Jbjs.G.00409","volume":"90a","author":"SJ Suratwala","year":"2008","unstructured":"Suratwala SJ, Cho SK, van Raalte JJ, Park SH, Seo SW, Chang SS, et al. Enhancement of periprosthetic bone quality with topical hydroxyapatite-bisphosphonate composite. J Bone Joint Surg Am. 2008;90a(10):2189\u201396. https:\/\/doi.org\/10.2106\/Jbjs.G.00409 PubMed PMID: WOS:000259873300017.","journal-title":"J Bone Joint Surg Am"},{"issue":"10","key":"4458_CR45","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1158\/1078-0432.Ccr-08-1616","volume":"15","author":"A Labrinidis","year":"2009","unstructured":"Labrinidis A, Hay S, Liapis V, Ponomarev V, Findlay DM, Evdokiou A. EZoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model. Clin Cancer Res. 2009;15(10):3451\u201361. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-08-1616 PubMed PMID: WOS:000266282600024.","journal-title":"Clin Cancer Res"},{"issue":"17","key":"4458_CR46","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1016\/j.biomaterials.2004.09.026","volume":"26","author":"C Wedemeyer","year":"2005","unstructured":"Wedemeyer C, von Knoch F, Pingsmann A, Hilken G, Sprecher C, Saxler G, et al. Stimulation of bone formation by zoledronic acid in particle-induced osteolysis. Biomaterials. 2005;26(17):3719\u201325. https:\/\/doi.org\/10.1016\/j.biomaterials.2004.09.026 PubMed PMID: WOS:000226968200038.","journal-title":"Biomaterials"},{"issue":"2","key":"4458_CR47","doi-asserted-by":"publisher","first-page":"347e","DOI":"10.1097\/01.prs.0000475780.68585.cc","volume":"137","author":"ZL Tang","year":"2016","unstructured":"Tang ZL, Bai S, Zhu PN, Li YD, Wang DX, Cai Y. An examination of differences in the new bone formation promoted by different doses of recombinant human parathyroid hormone during mandibular distraction osteogenesis. Plast Reconstr Surg. 2016;137(2):347e\u201354e. https:\/\/doi.org\/10.1097\/01.prs.0000475780.68585.cc PubMed PMID: WOS:000369444500001.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"4458_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00296-015-3319-9","volume":"36","author":"S Noordin","year":"2016","unstructured":"Noordin S, Glowacki J. Parathyroid hormone and its receptor gene polymorphisms: implications in osteoporosis and in fracture healing. Rheumatol Int. 2016;36(1):1\u20136. https:\/\/doi.org\/10.1007\/s00296-015-3319-9 PubMed PMID: WOS:000367808500001.","journal-title":"Rheumatol Int"},{"issue":"4","key":"4458_CR49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1055\/s-0034-1382069","volume":"218","author":"AS Winarno","year":"2014","unstructured":"Winarno AS, Kyvernitakis I, Hadji P. Successful treatment of 1\u201334 parathyroid hormone (pth) after failure of bisphosphonate therapy in a complex case of pregnancy associated osteoporosis and multiple fractures. Z Geburtsh Neonatol. 2014;218(4):171\u20133. https:\/\/doi.org\/10.1055\/s-0034-1382069 PubMed PMID: WOS:000340831000010.","journal-title":"Z Geburtsh Neonatol"},{"issue":"3","key":"4458_CR50","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00198-015-3331-7","volume":"27","author":"V Hegde","year":"2016","unstructured":"Hegde V, Jo JE, Andreopoulou P, Lane JM. Effect of osteoporosis medications on fracture healing. Osteoporosis Int. 2016;27(3):861\u201371. https:\/\/doi.org\/10.1007\/s00198-015-3331-7 PubMed PMID: WOS:000371311400003.","journal-title":"Osteoporosis Int"},{"issue":"31\u201332","key":"4458_CR51","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1055\/s-0030-1262443","volume":"135","author":"CE Brunnemann","year":"2010","unstructured":"Brunnemann CE, Reisinger EC, Ganzer D, Schober HC. Parathyroid hormone injection to counteract delayed bone fractures. Deut Med Wochenschr. 2010;135(31\u201332):1538\u201341. https:\/\/doi.org\/10.1055\/s-0030-1262443 PubMed PMID: WOS:000280369300003.","journal-title":"Deut Med Wochenschr"},{"key":"4458_CR52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bone.2016.08.012","volume":"92","author":"M Casanova","year":"2016","unstructured":"Casanova M, Herelle J, Thomas M, Softley R, Schindeler A, Little D, et al. Effect of combined treatment with zoledronic acid and parathyroid hormone on mouse bone callus structure and composition. Bone. 2016;92:70\u20138. https:\/\/doi.org\/10.1016\/j.bone.2016.08.012 PubMed PMID: WOS:000385693400008.","journal-title":"Bone"},{"issue":"4","key":"4458_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3109\/17453674.2012.702388","volume":"83","author":"H Daugaard","year":"2012","unstructured":"Daugaard H, Elmengaard B, Andreassen TT, Lamberg A, Bechtold JE, Soballe K. Systemic intermittent parathyroid hormone treatment improves osseointegration of press-fit inserted implants in cancellous bone A canine study. Acta Orthopaedica. 2012;83(4):411\u20139. https:\/\/doi.org\/10.3109\/17453674.2012.702388 PubMed PMID: WOS:000307848600016.","journal-title":"Acta Orthopaedica"},{"issue":"2","key":"4458_CR54","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jbm.a.31087","volume":"81a","author":"RD Bloebaum","year":"2007","unstructured":"Bloebaum RD, Willie BM, Mitchell BS, Hofmann AA. Relationship between bone ingrowth, mineral apposition rate, and osteoblast activity. J Biomed Mater Res Part A. 2007;81a(2):505\u201314. https:\/\/doi.org\/10.1002\/jbm.a.31087 PubMed PMID: WOS:000245688500028.","journal-title":"J Biomed Mater Res Part A"},{"issue":"9","key":"4458_CR55","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s10856-012-4682-7","volume":"23","author":"XH Yu","year":"2012","unstructured":"Yu XH, Wang LP, Jiang X, Rowe D, Wei M. Biomimetic CaP coating incorporated with parathyroid hormone improves the osseointegration of titanium implant. J Mater Sci-Mater M. 2012;23(9):2177\u201386. https:\/\/doi.org\/10.1007\/s10856-012-4682-7 PubMed PMID: WOS:000308242000014.","journal-title":"J Mater Sci-Mater M"},{"issue":"4","key":"4458_CR56","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3899\/jrheum.100980","volume":"38","author":"A Zati","year":"2011","unstructured":"Zati A, Sarti D, Malaguti MC, Pratelli L. Teriparatide in the treatment of a loose hip prosthesis. J Rheumatol. 2011;38(4):778\u201380. https:\/\/doi.org\/10.3899\/jrheum.100980 PubMed PMID: WOS:000289333800035.","journal-title":"J Rheumatol"},{"issue":"6","key":"4458_CR57","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00198-009-1031-x","volume":"21","author":"R Dayer","year":"2010","unstructured":"Dayer R, Brennan TC, Rizzoli R, Ammann P. PTH improves titanium implant fixation more than pamidronate or renutrition in osteopenic rats chronically fed a low protein diet. Osteoporosis Int. 2010;21(6):957\u201367. https:\/\/doi.org\/10.1007\/s00198-009-1031-x PubMed PMID: WOS:000277204100008.","journal-title":"Osteoporosis Int"},{"issue":"2","key":"4458_CR58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s00776-008-1311-x","volume":"14","author":"R Skripitz","year":"2009","unstructured":"Skripitz R, Johansson HR, Ulrich SD, Werner A, Aspenberg P. Effect of alendronate and intermittent parathyroid hormone on implant fixation in ovariectomized rats. J Orthop Sci. 2009;14(2):138\u201343. https:\/\/doi.org\/10.1007\/s00776-008-1311-x PubMed PMID: WOS:000264838400003.","journal-title":"J Orthop Sci"},{"key":"4458_CR59","unstructured":"Daugaard H. The influence of Parathyroid hormone treatment on implant fixation. Dan Med Bull. 2011;58(9):B4317. PubMed PMID: WOS:000297626800008."}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04458-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-021-04458-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04458-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T09:06:39Z","timestamp":1624525599000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04458-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4458"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04458-4","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]},"assertion":[{"value":"26 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were inspected and approved by the Ethic and Animal Welfare Committee of the Affiliated Hospital of Qingdao University, confirming that all experiments were performed in accordance with relevant guidelines and regulations (Approval Number: N02165782). The study was carried out in compliance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"580"}}